A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02285205 |
Recruitment Status :
Completed
First Posted : November 6, 2014
Last Update Posted : February 2, 2016
|
Sponsor:
Yonsei University
Information provided by (Responsible Party):
Yonsei University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | November 2015 |
Actual Study Completion Date : | November 2015 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):